Grants and Contributions:
Title:
AI-guided high-throughput platform for developing encapsulated therapeutics
Agreement Number:
1034991
Agreement Value:
$75,000.00
Agreement Date:
Sep 1, 2025 - May 29, 2026
Description:
Development and commercialization readiness of an AI-driven high-throughput platform for therapeutic nanoparticle formulation, combining an innovative pumpless consumable with an intelligent software assistant.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H3C 0B4
Reference Number:
172-2025-2026-Q3-1034991
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
796600351
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days. The total amended value is 75,000 dollars.
Amendment Date
Dec 4, 2025
Recipient's Operating Name:
Nanofacile Inc.
Recipient's Legal Name:
Nanofacile inc.
Federal Riding Name:
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number:
24077
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: